BEAM
Beam Therapeutics Inc
Price:  
34.14 
USD
Volume:  
2,172,856.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BEAM Stock Forecast & Price Target

BEAM Stock Price Forecast

The average stock forecast for Beam Therapeutics Inc (BEAM) in the next 12 months is 51.02 USD. This price target corresponds to an upside of 57.09%. The range of stock forecasts for BEAM is 26.26 - 84.00 USD. Based on the ratings of 25 analysts, the consensus recommendation for BEAM is STRONGBUY.
Target Low Average Median High
Price (USD) 26.26 51.02 47.25 84.00
Upside -19.15% 57.09% 45.46% 158.62%

Recommendation Trends

The latest consensus rating for BEAM is "STRONGBUY". This is the average recommendation of 25 analysts: 0 strong sell, 0 sell, 3 hold, 11 buy, 11 strong buy. In the previous period, 25 analysts also majorly recommmended "STRONGBUY" for BEAM.

BEAM Financial Stock Forecast

Revenue This Year
80.23M
-42.58%
from 139.74M
Revenue Next Year
96.85M
20.71%
from 80.23M
EPS This Year
-4.46
473.30%
from -0.78
EPS Next Year
-4.58
2.68%
from -4.46